Literature DB >> 26497792

Retinal ganglion cell dendrite pathology and synapse loss: Implications for glaucoma.

Jessica Agostinone1, Adriana Di Polo2.   

Abstract

Dendrites are exquisitely specialized cellular compartments that critically influence how neurons collect and process information. Retinal ganglion cell (RGC) dendrites receive synaptic inputs from bipolar and amacrine cells, thus allowing cell-to-cell communication and flow of visual information. In glaucoma, damage to RGC axons results in progressive neurodegeneration and vision loss. Recent data indicate that axonal injury triggers rapid structural alterations in RGC dendritic arbors, prior to manifest axonal loss, which lead to synaptic rearrangements and functional deficits. Here, we provide an update on recent work addressing the role of RGC dendritic degeneration in models of acute and chronic optic nerve damage as well as novel mechanisms that regulate RGC dendrite stability. A better understanding of how defects in RGC dendrites contribute to neurodegeneration in glaucoma might provide new insights into disease onset and progression, while informing the development of novel therapies to prevent vision loss.
© 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Axonal injury; Dendrite; Glaucoma; Ocular hypertension; Retinal ganglion cell; Synapse

Mesh:

Year:  2015        PMID: 26497792     DOI: 10.1016/bs.pbr.2015.04.012

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  26 in total

Review 1.  Axon injury signaling and compartmentalized injury response in glaucoma.

Authors:  Stephanie B Syc-Mazurek; Richard T Libby
Journal:  Prog Retin Eye Res       Date:  2019-07-10       Impact factor: 21.198

2.  The m6A reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells.

Authors:  Fugui Niu; Peng Han; Jian Zhang; Yuanchu She; Lixin Yang; Jun Yu; Mengru Zhuang; Kezhen Tang; Yuwei Shi; Baisheng Yang; Chunqiao Liu; Bo Peng; Sheng-Jian Ji
Journal:  Elife       Date:  2022-02-18       Impact factor: 8.140

3.  Axonal architecture of the mouse inner retina revealed by second harmonic generation.

Authors:  Arafat Meah; Vinessia Boodram; Festa Bucinca-Cupallari; Hyungsik Lim
Journal:  PNAS Nexus       Date:  2022-08-16

Review 4.  Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma.

Authors:  Sanaz Behtaj; Andreas Öchsner; Yuri G Anissimov; Maksym Rybachuk
Journal:  Tissue Eng Regen Med       Date:  2020-05-10       Impact factor: 4.169

5.  Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.

Authors:  Marius Chiasseu; Jorge L Cueva Vargas; Laurie Destroismaisons; Christine Vande Velde; Nicole Leclerc; Adriana Di Polo
Journal:  J Neurosci       Date:  2016-05-25       Impact factor: 6.167

6.  [Changes of membrane properties and synaptic stability of rat retinal ganglion cells during postnatal development].

Authors:  Siqi Yu; Zhengrong Lin; Zhongju Xiao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-08-30

Review 7.  Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration.

Authors:  Sara Al Hussein Al Awamlh; Lauren K Wareham; Michael L Risner; David J Calkins
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 8.  Discovery and clinical translation of novel glaucoma biomarkers.

Authors:  Gala Beykin; Anthony M Norcia; Vivek J Srinivasan; Alfredo Dubra; Jeffrey L Goldberg
Journal:  Prog Retin Eye Res       Date:  2020-07-10       Impact factor: 21.198

9.  A Fair Assessment of Evaluation Tools for the Murine Microbead Occlusion Model of Glaucoma.

Authors:  Marie Claes; Joana R F Santos; Luca Masin; Lien Cools; Benjamin M Davis; Lutgarde Arckens; Karl Farrow; Lies De Groef; Lieve Moons
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

10.  AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma.

Authors:  Nicolas Belforte; Jessica Agostinone; Luis Alarcon-Martinez; Deborah Villafranca-Baughman; Florence Dotigny; Jorge L Cueva Vargas; Adriana Di Polo
Journal:  Mol Neurodegener       Date:  2021-06-29       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.